Recommendations for prevention of contrast-media induced npropathy;Recommandations concernant la prévention de la néphropathie aux produits de contraste iodés

Nephrologie

Volumn 25, Issue 4, 2004, Pages 149-150

  Arkouche, W ^a   Brillet, G ^a   Cao Huu, T ^a   Issad, B ^a   Siohan, P ^a   Souid, M ^a   Stroumza, P ^a   Tollis, F ^a   Urena, P ^a   Pengloan, Josette ^a,b  

^a Societe de Nephrologie ^*  (France)

^b CHU BRETONNEAU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BIGUANIDE DERIVATIVE; CIDOFOVIR; CONTRAST MEDIUM; FOSCARNET; IFOSFAMIDE; INTERLEUKIN 2; METHOTREXATE; SULFADIAZINE;

CHRONIC KIDNEY FAILURE; CREATININE CLEARANCE; DEHYDRATION; DIABETES MELLITUS; HUMAN; HYPOTENSION; KIDNEY BLOOD FLOW; KIDNEY DISEASE; NEPHROTOXICITY; RISK FACTOR; SHORT SURVEY;

CONTRAST MEDIA; CREATININE; DEHYDRATION; FEMALE; HUMANS; KIDNEY DISEASES; MALE; RISK ASSESSMENT; RISK FACTORS;

EID: 3042735003     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (12)

1. Birck R, Krzzossok S, Markowetz F, Schnulle P, van der Woude FJ, Braun C. Acetylcysteine for prevention of contrast nephropathy: Meta-analysis. Lancet 2003; 362: 598-603.
2. Kay J, Chow WH, Chan TM, Lo SK, Kwok OH, Yip A, Fan K, Lee CH, Lam WF. Acetylcysteine for prevention of acute deterioration renal function following elective coronary angiography and intervention: A randomized controlled trial. JAMA 2003; 5: 553-8.
3. Trivedi HS, Moore N, Nasr S, Aggarwall K, Agrawal A, Goel P, Hewett J. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003; 1: C29-34.
4. Briguori C, Manganelli F, Scarpato P, Elia PP, Golia B, Riviezzo G, Lepore S, Librera M, Villari B, Colombo A, Ricciardelli B. Acetylcysteine and Contrast Agent-Associated Nephrotoxicity. J Am Coll Cardiol 2002; 40: 298-303.
5. Freeman RV, Odonnell M, Share D, Meengs WL, Kline-Rogers E, Clark VL, DeFranco AC, Eagle KA, McGinnity JG, Patel K, Maxwell-Eward A, Bondie D, Moscucci M; (BMC2). Nephropathy requiring dialysis after percutaneous coronary intervention and the critical role of an adjusted contrast dose. Am J Cardiol 2002; 10: 1068-73.
6. Huber W, Jeschke, Kreymann B, Hennig M, Page M, Salmhofer H, Eckel F, Schmidt U, Umgelter A, Schweigert U, Classen M. Haemodialysis for the prevention of contrast-induced nephropathy: Outcome of 31 patients with severely impaired renal function, comparison with patients similar risk and review. Invest Radiol 2002; 9: 471-81.
7. Morcos SK, Thomsen HS, Web JA. Dialysis and contrast media Contrast Media Safety Committee of the European Society of Urogenital Radiology (ESUR). Eur Radiol 2002; 12: 3026-30.
8. Shinoda T, Hata T, Nakajima K, Yoshimoto H, Niwa A. Time-course of iodine elimination by hemodialysis in patients with renal failure after angiography. Ther Apher 2002; 6: 437-42.
9. Mueller C, Buerke G, Buettner HJ, Petersen J, Perruchoud AP, Eriksson U, Marssh S, Roskamm H. Prevention of Contrast Media-Associated Nephropathy-Randomized comparison of 2 hydration regimen in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002; 162: 329-36.
10. Vogt B, Ferrari P, Schonholzer C, Marti HP, mohaupt M, Wierderkehr M, Cereghetti C, Serra A, Huynh-Do U, Uehlinger D, Frey FJ. Prophylactic Hemodialysis after radiocontrast media in Patients with Renal Insufficiency is Potentially Harmful. Am J Med 2001; 111: 692-8.
11. Sterner G, Frennby B, Kurkus J, Nyman U. Does post-angiographic hemodialysis reduce the risk of contrast-medium nephropathy? Scand J Urol Nephrol 2000; 5: 323-6.
12. Lehnert T, Keller E, Gondolf K, Schaffner T, Pavenstadt H, Schollmeyer R Effect of hemodialysis after contrast medium administration in patients with renal insufficiency. Nephrol Dial Transplant 1998; 13: 358-62.